Single domain antibodies and their use in cancer therapies
Grant
US12594302B2
Kind: B2
Apr 07, 2026
Assignee
Institut Curie
Inventors
Sandrine Moutel, Franck Perez, Michele Bernasconi, Nagjie Laila Alijaj, Zélia Gouveia
Abstract
The present application relates to fully humanized anti-FGFR4 single domain antibodies (sdAbs) and variants thereof. The present invention further relates to functionalized drug nanocarriers, nucleic acids, vectors, host cells, immune cells comprising said sdAbs, and compositions comprising thereof, as well as their use for therapy.
CPC Classifications
C07K 16/2863
A61K 40/31
Filing Date
2021-05-20
Application No.
17925411
Claims
24